Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University
About this trial
The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.
Eligibility criteria
Qualifiers
be 18 years of age or older
be fluent in English
self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
Disqualifiers
report current mental health treatment ≥1 day/mo
report having received any CBT in the past 3 months
report current alcohol or drug abuse treatment, except mutual self-help (e.g., Alcoholics Anonymous)
need alcohol detoxification indicated by ≥9 on Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
Trial design
Treatments tested in this trial
- LGBTQ-affirmative Cognitive Behavioral Therapy
- LGBTQ-affirmative Treatment-As-Usual
Treatment groups
274 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov